SUMMARY -Th e incidence of pregnancy related diabetes has been steadily increasing during the past decade. Th e aim of this retrospective study was to evaluate the type and prevalence of gestational diabetes complications after implementing new diagnostic criteria for gestational diabetes. Th e incidence of gestational diabetes, maternal age, mode of delivery and birth weight were analyzed. Study patients were divided into three groups. Th e fi rst group consisted of patients who gave birth during 2005, the second group during 2011 and the third group during 2012. In 2005, the World Health Organization criteria were used on diagnosing gestational diabetes, whereas in 2011 and 2012 the criteria issued by the International Association of Diabetes and Pregnancy Study Groups were considered. Th ere was no statistically signifi cant diff erence among the groups according to maternal age, birth weight (p=0.203) and mode of delivery (p=0.883). Cesarean section was performed in about 30% of deliveries in all groups combined. Th ere was no signifi cant diff erence in the number of neonatal hypertrophy (p=0.348), although the distribution of hypertrophy showed a tendency towards higher values in 2005. Th e incidence of gestational diabetes was 2.2% in 2005, 6.6% in 2011 and 12% in 2012. In conclusion, diff erence in the incidence of pregnancy related diabetes appeared to have resulted directly from using diff erent diagnostic criteria. Th e new criteria contributed to a relatively higher incidence of gestational diabetes but also achieved better gestational glycemic control and consequently better fetal growth regulation.
Introduction
Diabetes mellitus type 2 is nowadays a widespread condition in the general population with potentially numerous complications. New diagnostic criteria may infl uence the incidence and possibly outcomes as well. Undertreated gestational diabetes can lead to various complications of pregnancy, labor and perinatal outcome with long lasting repercussions. Gestational diabetes is diabetes fi rst diagnosed during pregnancy. Th e defi nition includes previously unrecognized diabetes and impaired glucose tolerance 1, 2 . Obesity and disturbances of carbohydrate metabolism are the main reasons for the increased incidence of gestational diabetes.
Diagnostic criteria for gestational diabetes vary widely. Until 2010, the most often used criteria were the World Health Organization (WHO) guidelines including oral glucose tolerance test (OGTT) from capillary blood glucose 6.1 mmol/L and 7.8 mmol/L after 2 hours, measured during the third trimester after ultrasonic proof of fetal hypertrophy, polyhydramnion or placental changes 3 . Th is enabled detection of gestational diabetes mostly during the second half of pregnancy, and the need for earlier diagnosis was recognized. Changing the criteria should have especially been focused on ensuring early diagnosis and proper management before the onset of gestational diabetes complications.
Th e International Association of Diabetes and Pregnancy Study Groups (IADPSG) has assembled guidelines that can be used as refi ned diagnostic criteria and has classifi ed gestational diabetes based on the Hyperglycemia and Adverse Pregnancy Outcome study (HAPO study) that recommends diagnosing gestational diabetes based on venous plasma glucose values 4 . Th e results indicate the diagnosis when fasting venous plasma glucose up to 20 weeks of pregnancy is ≥5.1 mmol/L. Th is should be supported with the OGTT; when done at 24-32 weeks of gestation, fasting venous plasma glucose should be ≥5.1 mmol/L, followed by ≥10.0 mmol/L after 1 hour and fi nally ≥8.5 mmol/L 2 hours after glucose intake. If one or more of these values are equal or higher after 75-g OGTT, the diagnosis of gestational diabetes should be established. Overt diabetes can be diagnosed when fasting plasma glucose is ≥7.0 mmol/L, HbA1c level ≥6.5% or random plasma glucose over 11.1 mmol/L 5 . Th e aim of this retrospective study was to evaluate the type and incidence of gestational diabetes complications after implementation of the new diagnostic criteria for gestational diabetes at the Department of Obstetrics, Sestre milosrdnice University Hospital Center in Zagreb, Croatia.
Patients and Methods
Data from the maternity ward were retrospectively collected. Th e age of diabetic mothers, body mass index (BMI), gestational weight gain, mode of delivery and birth weight recorded in 2005 were compared with those recorded in 2011 and 2012. In 2005, the WHO criteria were used for detection of gestational diabetes, whereas in 2011 and 2012 the HAPO study guidelines were implemented. Statistical analyses were performed by the SPSS version 13.0 (SPSS, Chicago, IL, USA) using Student's t-test and c 2 -test.
Results
Total number of deliveries in 2005 was 2359, of which 52 (2.2%) women were diagnosed with gestational diabetes. In 2011, total number of deliveries was 3250 with a 6.6% incidence of gestational diabetes (n=214). In 2012, 3157 women delivered in our Hospital and the number of patients with gestational diabetes increased to 12% (n=379). Th e mean age of patients from all three groups was 31±4.3 years. Median BMI in all groups was the same, i.e. 22 before pregnancy and 27 upon admission to the hospital for delivery. However, median weight gain during pregnancy in 2011 and 2012 was 12 kg as compared with 14 kg in 2005. Th e mean maternal body weight at the beginning of pregnancy was 61 kg. Figure 4 . Due to the sample characteristics, no statistical test other than descriptive statistics could be employed for this parameter.
Discussion
Th e growing incidence of obesity and carbohydrate metabolic disorders poses a major problem in pregnant women with gestational diabetes 6 . Repercussions of gestational diabetes include fetal macrosomia, birth trauma to both mother and newborn, the need of labor induction or cesarean section, transient neonatal morbidity, neonatal hypoglycemia, perinatal death, obesity and/or diabetes developing later in the newborn's life. Th e incidence varies among ethnic groups, increases with obesity, maternal age and known genetic predisposition 7, 8 . Th e criteria for diagnosing diabetes in pregnant women are diff erent from those in general population. In the beginning of pregnancy, increasing hormone levels exert combined proinsulin and anabolic actions, while later during pregnancy, diabetogenic hormones infl uence glucose utilization, especially in third trimester, and increase insulin utilization by more than fourfold. If there is already weakness of pancreatic beta cell islets of Langerhans, diff erent degrees of glucose intolerance will manifest 3, 9 . Th ere are no uniform criteria for the diagnosis of gestational diabetes. O'Sullivan's OGTT criteria, the National Diabetes Data Group (NDDG) criteria and WHO criteria can be used for successful detection of a portion of pregnant women with diabetes 3 . Th e HAPO study was launched to explain the observed clinical trend of poor outcomes in pregnancies with diff erent grades of glucose intolerance. Conclusions of the HAPO study stated that the incidence of high birth weight, C-peptide levels in the umbilical cord, or the percentage of fat in the body weight of a fetus greater than 90 percentile was twofold greater if glucose value was equal to or higher than the limit value. Th e incidence of preeclampsia was twice higher if one or more glucose values were equal to or higher than the limit values and the incidence of premature births and primary cesarean sections was higher than 45%. Since 2011, the IADPSG criteria are in use in our Department. Th ese guidelines contribute to better risk group identifi cation and stratifi cation, but also change the method and extent of monitoring a large number of pregnant women [10] [11] [12] . In our Department, the incidence of gestational diabetes was 2.2% in 2005, 6.6% in 2011 and 12.0% in 2012. In the HAPO study, the overall percentage of pregnant women with gestational diabetes was 17.8%. Due to the changed criteria for gestational diabetes, in 2005 we had only 2.2% of patients with gestational diabetes in comparison with 2011 and 2012 when the new and stricter criteria were applied. Th e diff erence in the incidence between 2011 and 2012 can be explained by further adjusting the implementation of the new criteria. A large Chinese study compared the incidence and outcome of pregnancy under NDDG and IADPSG criteria. Th e prevalence of gestational diabetes when using IADPSG criteria was 18.9%. Th e prevalence of cesarean section, macrosomia, hypoglycemia, neonatal and perinatal death was signifi cantly lower when the IADPSG criteria were used 13 . Th e rate of cesarean sections in the group with IADPSG criteria was 46% and was signifi cantly lower than in the group with NDDG criteria. In our study population, the mean weight at the beginning of pregnancy was 61 kg in all groups, while at the end of pregnancy it was 74 kg in 2005 and 72 kg in 2011 and 2012. We found no statistically signifi cant diff erence in the maternal mean weight or BMI among the three groups, but there was a slight decrease of gestational weight gain in 2011 and 2012. Th ese data may indicate better dietary control and therefore lower weight gain in the 2011 and 2012 groups. In our study, cesarean section was performed in 30% of patients regardless of the criteria ap- Th e percentage of macrosomic children in the Chinese study and our study using IADPSG criteria was similar (6.3% and 7.6%, respectively). Th e increase in the number of pregnant women with gestational diabetes is an additional fi nancial burden on the healthcare system but it brings long-term savings by preventing morbidity both during pregnancy and in the child's later life 14, 15 . Newborns of mothers with gestational diabetes have a higher risk of developing psychomotor disorders and schizophrenia. Th is alone should encourage monitoring and treating even mild hyperglycemia in pregnancy, as evidenced by the ACHOIS and MFMU studies 16, 17 . Th e high prevalence of gestational diabetes can be explained by the worldwide epidemic of obesity, prediabetes and diabetes 18 . Although we have tried to utilize uniform criteria for timely and accurate diagnosis and monitoring of pregnant women with gestational diabetes, it seems that the process will not always go as anticipated due to many resistances to introducing new criteria. Al-though the results of HAPO study clearly show a lower incidence of macrosomic children, preeclampsia, preterm delivery, shoulder dystocia and birth injuries, the methodology and results of the HAPO study are under constant criticism 19 . Th e US National Institute of Health has not accepted the IADPSG recommendations, deeming the consequent prevalence of gestational diabetes too high and without objective justification. Th ey are actively working on the adoption and refi ning their own guidelines 20, 21 . It should be noted that no clinical study showed negative eff ect of utilizing the IADPSG based treatment of gestational diabetes. On the contrary, the results of the HAPO study clearly put the fetus in the center of interest in pregnant women with gestational diabetes and stress the importance of observing the fetus as a patient. Th e importance of maintaining an optimal intrauterine environment is not only a prerequisite for good perinatal outcome, but also provides conditions that encourage full development of fetal potential and minimize late eff ects of gestational diabetes. It is known that children from unregulated pregnancies with gestational diabetes often develop obesity, metabolic syndrome and have diffi culties with social intercourse. Th is concept of fetal programming has been studied widely in clinical, epidemiological and animal studies 22, 23 . During the few months of pregnancy, the diagnosis and treatment of gestational diabetes do not endanger the health and life of pregnant women, but it might be an additional motivation to adopt healthy habits and a quality lifestyle after pregnancy. Th is is the best way to prevent the development of diabetes type 2, to which many of the healthy and especially gestational diabetes women are predisposed to develop later in life.
Conclusion
In our study, no signifi cant diff erences in birth weight and mode of delivery were found in patients with gestational diabetes according to the two diff erent diagnostic criteria. Th ere was, however, a significant diff erence in the distribution of higher birth weight, showing the use of the IADPSG criteria to be associated with lower neonatal weight values in patients with gestational diabetes. Th e incidence trends similar to the HAPO study results can be expected in the future. In 2011 and 2012, better maternal glycemic control and therefore a decreased number of hypertrophic children were recorded. We found no statistically signifi cant diff erence in the maternal mean weight and BMI among the three groups, but there was a slight decrease of gestational weight gain in 2011 and 2012. Th ese data may indicate better dietary control and therefore lower weight gain in the 2011 and 2012 groups. Although these new diagnostic criteria have not been widely accepted, our results showed benefi ts for both the mother and the baby.
